Position in PFE
as of Jun 30, 2026
· filed Jul 14, 2026
Position Value
$934,375
+$243,412 QoQ
Shares Held
38,803
+57.7% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#1,366
of 2,821 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026SIGNATURE ESTATE & INVESTMENT ADVISORS LLC holds $78,743,107 across 9 Drug Manufacturers - General names. PFE ranks #6 (1.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
57,559 | $69,037,996 | |
| 2 | JNJ |
Johnson & Johnson
|
8,972 | $2,278,618 | |
| 3 | AMGN |
Amgen Inc
|
6,232 | $2,256,731 | |
| 4 | ABBV |
AbbVie Inc.
|
5,312 | $1,336,711 | |
| 5 | AZN |
Astrazeneca PLC
|
6,802 | $1,289,794 | |
| 6 | PFE |
Pfizer Inc
This page
|
38,803 | $934,375 | |
| 7 | MRK |
Merck & Co., Inc.
|
7,229 | $928,926 | |
| 8 | NVO |
Novo Nordisk A S
|
8,810 | $422,350 |
All Filings in PFE
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $934,375 | 38,803 | Shares | Sole | 2026-07-14 | |
| 2026-03-31 | $690,963 | 24,607 | Shares | Sole | 2026-04-15 | |
| 2025-12-31 | $630,667 | 25,328 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $619,825 | 24,326 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $556,937 | 22,976 | Shares | Defined | 2025-07-29 | |
| 2025-03-31 | $487,895 | 19,254 | Shares | Sole | 2025-05-16 | |
| 2024-12-31 | $497,914 | 18,768 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $545,113 | 18,836 | Shares | Defined | 2024-11-06 | |
| 2024-06-30 | $598,603 | 21,394 | Shares | Defined | 2024-07-26 | |
| 2024-03-31 | $288,155 | 10,384 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $305,432 | 10,609 | Shares | Defined | 2024-01-29 | |
| 2023-09-30 | $422,684 | 12,743 | Shares | Defined | 2023-10-26 | |
| 2023-06-30 | $468,366 | 12,769 | Shares | Defined | 2023-07-20 | |
| 2023-03-31 | $281,356 | 6,896 | Shares | Defined | 2023-05-03 | |
| 2022-12-31 | $344,127 | 6,716 | Shares | Defined | 2023-01-11 | |
| 2022-09-30 | $279,231 | 6,381 | Shares | Defined | 2022-10-20 | |
| 2022-06-30 | $413,567 | 7,888 | Shares | Defined | 2022-07-13 | |
| 2022-03-31 | $327,910 | 6,334 | Shares | Defined | 2022-04-19 | |
| 2021-12-31 | $501,983 | 8,501 | Shares | Defined | 2022-01-20 | |
| 2021-09-30 | $364,896 | 8,484 | Shares | Defined | 2021-10-12 | |
| 2021-06-30 | $329,531 | 8,415 | Shares | Defined | 2021-07-16 | |
| 2021-03-31 | $308,425 | 8,513 | Shares | Defined | 2021-04-15 | |
| 2020-12-31 | $360,884 | 9,804 | Shares | Defined | 2021-01-13 | |
| 2020-09-30 | $298,406 | 8,131 | Shares | Defined | 2020-10-13 | |
| 2020-06-30 | $230,599 | 7,052 | Shares | Defined | 2020-07-21 | |
| No filing history on record for this holder in this stock. | ||||||